Amoxicillin outperforms penicillin V in treating pediatric pneumonia, study finds

FHS
June 18, 2024
5:29 am

A recent study confirmed amoxicillin’s lower risk of treatment failure compared to penicillin V in treating pediatric pneumonia, with no difference in severe complications.

EMA asks for more information after safety signal arises for GLP-1s, semaglutide in thyroid cancer

The European Medicines Agency is concerned there could be a potential link between thyroid cancer and the use of glucagon-like peptide-1 (GLP-1) receptor agonists, which

June 23, 2023

Oral ketamine tablets effective for treating depression, new study finds

The results of a randomized controlled trial published Monday showed oral ketamine tablets were safe and effective for patients with treatment-resistant depression — the latest

June 24, 2024

Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch

VABYSMO gained FDA approval in January 2022. Credit: Jo Panuwat D via Shutterstock. Last week, Roche released promising first-quarter (Q1) 2024 sales figures for VABYSMO,

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.